LPWM
BPMC

Lake Point Wealth Management’s Blueprint Medicines BPMC Stock Holding History

Lake Point Wealth Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-79
Closed -$5K – 449
2022
Q1 		$5K Hold
79
– – ﹤0.01% 238
2021
Q4 		$8K Hold
79
– – ﹤0.01% 195
2021
Q3 		$8K Hold
79
– – ﹤0.01% 181
2021
Q2 		$7K Buy
+79
New +$7.24K ﹤0.01% 208

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Lake Point Wealth Management's BPMC Position: Q2 2022 in Review

Lake Point Wealth Management sold out of Blueprint Medicines (BPMC) in Q2 2022, closing a stake of 79 shares — an estimated $5K sold.

Lake Point Wealth Management first reported a position in BPMC in Q2 2021 and held it in 4 quarters. The position peaked at $8K in Q4 2021. 237 funds tracked by Wall St. Rank hold BPMC as of Q2 2022.

  • Lake Point Wealth Management reported no remaining Blueprint Medicines position as of Q2 2022 after selling out during the quarter.
  • Lake Point Wealth Management sold 79 Blueprint Medicines shares in Q2 2022, an estimated $5K.
  • Lake Point Wealth Management first reported a position in Blueprint Medicines in Q2 2021 and held it in 4 quarters.
  • Lake Point Wealth Management's Blueprint Medicines position peaked at $8K in Q4 2021.
  • 237 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2022.

Based on Lake Point Wealth Management's 13F filing for Q2 2022, filed 19 Jul 2022.